Anuh Pharma Ltd
Anuh Pharma Ltd (ANUHPHR) last traded at ₹77.3, a market capitalisation of ₹774 crore, on a P/E of 17.5. Over the past 52 weeks the stock has ranged between ₹66.7 and ₹93. Anuh Pharma Ltd last reported results for the quarter ended Jun 2026, with sales of ₹194 crore and net profit of ₹11 crore. Figures are as of 25 Aug 2026 and are not real time.
Anuh Pharma Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Anuh Pharma Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹194 cr, up 4.3% from ₹186 cr a year earlier. Net profit was ₹11 cr, up 37.5% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 166 | 160 | 198 | 186 | 186 | 197 | 202 | 194 |
| Expenses | 149 | 145 | 179 | 176 | 174 | 178 | 182 | 178 |
| Operating profit | 17 | 15 | 19 | 10 | 12 | 19 | 20 | 16 |
| OPM % | 10% | 9% | 9% | 6% | 6% | 10% | 10% | 8% |
| Other income | 3 | 1 | 1 | 3 | 1 | 2 | -1 | 3 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 2 |
| Profit before tax | 18 | 13 | 17 | 11 | 10 | 18 | 16 | 17 |
| Tax % | 17% | 22% | 28% | 24% | 23% | 25% | 25% | 32% |
| Net profit | 15 | 10 | 12 | 8 | 8 | 13 | 12 | 11 |
| EPS (₹) | 1.50 | 1.03 | 1.24 | 0.83 | 0.76 | 1.34 | 1.17 | 1.14 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Anuh Pharma Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 432 | 487 | 527 | 647 | 662 | 772 | 779 |
| Operating profit | 45 | 47 | 52 | 76 | 62 | 62 | 67 |
| OPM % | 10% | 10% | 10% | 12% | 9% | 8% | 9% |
| Net profit | 28 | 31 | 36 | 60 | 47 | 41 | 44 |
| EPS (₹) | 2.84 | 3.05 | 3.61 | 5.99 | 4.73 | 4.10 | 4.41 |
TTM is the trailing twelve months to the most recent quarter.
Anuh Pharma Ltd growth and returns
- 10 Years
- 9%
- 5 Years
- 12%
- 3 Years
- 14%
- TTM
- 10%
- 10 Years
- 4%
- 5 Years
- 10%
- 3 Years
- 3%
- TTM
- -4%
- 10 Years
- 5%
- 5 Years
- 6%
- 3 Years
- 5%
- 1 Year
- -12%
- 10 Years
- 13%
- 5 Years
- 14%
- 3 Years
- 14%
- Last Year
- 11%
Anuh Pharma Ltd shareholding pattern
Promoters held 71.79% at Jun 2026, up from 69.91% at Jun 2025. FIIs 0.01% and DIIs 0.00%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 69.91% | 69.91% | 69.91% | 69.91% | 71.81% | 71.81% | 71.79% | 71.79% |
| FIIs | 0.02% | 0.02% | 0.04% | 0.04% | 0.00% | 0.00% | 0.05% | 0.01% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 30.06% | 30.07% | 30.04% | 30.04% | 28.19% | 28.17% | 28.14% | 28.19% |
| No. of shareholders | 23,910 | 24,279 | 24,235 | 24,257 | 28,250 | 27,889 | 27,425 | 27,484 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Anuh Pharma Ltd corporate filings
- Investor Presentation for Q1 FY 2026-27Company Updatehigh impact
Cruxal's analysis: Anuh Pharma Ltd. delivered a robust performance for Q1 FY27, reporting an operating…
Read the full analysis - Disclosure under Regulation 30 of SEBI (LODR), 2015 regarding Change in Management.Company Updatelow impact
Cruxal's analysis: Anuh Pharma Ltd. has concluded its 66th Annual General Meeting, confirming the…
Read the full analysis - Disclosure of Announcement under Regulation 30 of SEBI (LODR), 2015Company Updatelow impact
Cruxal's analysis: Anuh Pharma Ltd has filed a general disclosure under Regulation 30 of the SEBI (LODR)…
Read the full analysis - Submission of Scrutinizer Report and Voting Results for the 66th Annual General Meeting of the CompanyAGM/EGMlow impact
Cruxal's analysis: Anuh Pharma Limited has successfully concluded its 66th Annual General Meeting held on…
Read the full analysis - Outcome of the 66th Annual General Meeting of Anuh Pharma Limited held on Wednesday, 12th August, 2026AGM/EGMlow impact
Cruxal's analysis: Anuh Pharma Ltd. has successfully concluded its 66th Annual General Meeting held on 12th…
Read the full analysis - Newspaper Publication of the Unaudited financial results for the Quarter ended 30th June, 2026, published in the Financial Express in English Language and Mumbai Lakshdeep in Marathi Language ....Company Updatehigh impact
Cruxal's analysis: Anuh Pharma Ltd. has released its unaudited financial results for the quarter ended June…
Read the full analysis - Adoption of Revised Policy of Related Party Transactions.Company Updatelow impact
Cruxal's analysis: Anuh Pharma Ltd has formally adopted a revised policy concerning Related Party…
Read the full analysis - Request received for Withdrawal of application for reclassification of shareholding from "Promoter & Promoter Group'' to ''Public Category''.Company Updatelow impact
Cruxal's analysis: Anuh Pharma Ltd has formally requested the withdrawal of its previously submitted…
Read the full analysis - Unaudited Financial Results for the Quarter ended 30th June, 2026.Resulthigh impact
Cruxal's analysis: Anuh Pharma Ltd. reported a strong performance for the quarter ended 30th June 2026, with…
Read the full analysis - To consider and approve the Unaudited Financial results along with the Limited Review Report for the quarter ended 30th June, 2026, Request received for withdrawal of application for reclassification ....Board Meetinghigh impact
Cruxal's analysis: Anuh Pharma Limited reported a strong performance for the quarter ended 30th June 2026…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Anuh Pharma Ltd
Cruxal reads every Anuh Pharma Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.